Mylan Institutional has received final US Food and Drug Administration (FDA) approval for its abbreviated new drug application for Tranexamic Acid Injection, 100 mg/mL.
Subscribe to our email newsletter
Tranexamic Acid Injection, 100 mg/mL are packaged in 1,000 mg/10 mL Single-dose Vials.
This product is the generic version of Pharmacia & Upjohn’s Cyklokapron Injection.
Tranexamic Acid Injection is indicated for short-term use in patients with hemophilia to reduce or prevent hemorrhage during and following oral surgery.